A new diagnostic tool for Parkinson's disease
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by the misfolding and aggregation of α-synuclein into Lewy bodies. Understanding how the oligomers formed from this process cause cellular toxicity and disease is paramount to determining the molecular origins of PD. To address this issue, the EU-funded SUPD project will combine spectroscopy and fluorescent technologies to study α-synuclein oligomers in the cerebrospinal fluid of PD patients and healthy individuals. The generated method of measuring α-synuclein oligomer size and structural properties can serve as an early diagnostic tool for PD and may generate opportunities for therapeutic intervention.
Fields of science
Call for proposalSee other projects for this call
Funding SchemeMSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
CB2 1TN Cambridge
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
53706 Madison Wi
See on map